The Elite 3500 72V delivers a consistent finish, is easy to operate and is field serviceable, the company said. It’s a versatile, direct drive sprayer featuring proven Titan ...

Muse Paintbar is a paint-and-sip studio located at The Battery Atlanta. Guests are welcome to drop by the "open studio" from 2:00 p.m to 4:00 p.m. Tuesday afternoon. There’s also a packed ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

On Saturday, in the minutes before the Grade 1 Pegasus World Cup Invitational at Gulfstream Park in Hallandale Beach, Fla., 1/ST chairman and CEO Belinda Stronach went on camera with NBC to answer ...

To create the solid electrolyte, the researchers introduced an inert aluminum fluoride salt to the liquid electrolyte already containing aluminum ions.

A stretchy and flexible battery pouch filled with strategically placed holes is more breathable than cotton. That could make it an ideal power source for wearable sports or fitness devices built ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Tata Group's $1.5 billion initial investment to build a battery gigafactory in India and supply Tata Motors will allow it to further integrate its supply chain, P.B. Balaji, group CFO at Tata ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...